Home » Topics » Regulatory » Patents

Patents
RSS

Centrally active adrenergic agents in development at Pierre Fabre

April 3, 1998

Neurogen prepares new class of brain GABA receptor ligands

April 3, 1998

New inhibitors of cell adhesion in development at Kao

April 3, 1998

Banyu develops factor Xa inhibitors as antiplatelet/antithrombotic agents

April 2, 1998

Mochida prepares novel agents for disorders associated with eosinophilia

April 2, 1998

Broad-spectrum antibacterial agents synthesized by Daiichi

April 2, 1998

Schering-Plough presents new agents for cognitive disorders

April 2, 1998

New compounds synthesized at HMR upregulate LDL receptors

April 2, 1998

Synthelabo claims compounds with selective affinity for certain GABA-A receptors

April 1, 1998

Novel therapies for type II diabetes disclosed by HMR

April 1, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...